A Phase 1 study of BAY3563254 in metastatic castration-resistant prostate cancer
Recruiting Phase 1 NCT06217822
Study Description
A First-in-Human Study of a Novel Radiation Therapy for Advanced Prostate Cancer
Study Details
- Registry ID:
- NCT06217822
- Conditions:
- Advanced Metastatic Castration-resistant Prostate Cancer, Prostate Specific Membrane Antigen (PSMA) Expression
- Phase:
- Phase 1
- Target Enrollment:
- 198 participants
- Start Date:
- Healthy Volunteers:
- No
Study Locations (67 sites)
-
IRCCS Istituto Nazionale Tumori Fondazione Pascale - S. C. Medicina Nucleare e Terapia Metabolica
Naples, Italy -
IRCCS Istituto Nazionale Tumori Fondazione Pascale - S. C. Medicina Nucleare e Terapia Metabolica
Napoli, Italy -
Istituto Europeo di Oncologia s.r.l - Medicina Nucleare
Milan, Italy -
Istituto Europeo di Oncologia s.r.l - Medicina Nucleare
Milano, Italy -
UniversitätsSpital Zürich (USZ) - Klinik für Medizinische Onkologie und Hämatologie
Zurich, Switzerland -
Univestitätsspital Zürich (USZ)
Zurich, Switzerland -
Universitätsspital Basel
Basel, Canton of Basel-City, Switzerland -
Kantonsspital Baden
Baden, Aargau, Switzerland -
AZ Groeninge Campus Kennedylaan - Urology
Kortrijk, Belgium -
AZ Groeninge Campus Kennedylaan - Urology
Kortrijk, West Flanders, Belgium -
Institut Jules Bordet / Nuclear Medicine
Anderlecht, Belgium -
Institut Jules Bordet / Nuclear Medicine
Anderlecht, Brussels Capital, Belgium -
UZ Leuven - Campus Gasthuisberg - Nuclear Medicine
Leuven, Belgium -
UZ Leuven - Campus Gasthuisberg - Nuclear Medicine
Leuven, Flemish Brabant, Belgium -
The Royal Marsden NHS Foundation Trust | Sutton - Oak Foundation Drug Development Unit
Sutton, Surrey, United Kingdom -
Royal Marsden NHS Trust (Surrey)
Sutton, Surrey, United Kingdom -
University College London Hospitals NHS Foundation Trust | University College Hospital - NIHR UCLH Clinical Research Facility
London, United Kingdom -
University College London Hospitals NHS Foundation Trust
London, United Kingdom -
University College London Hospitals NHS Foundation Trust | University College Hospital - NIHR UCLH Clinical Research Facility
London, Greater London, United Kingdom -
Universitair Medisch Centrum Groningen (UMCG) - UMC Groningen Comprehensive Cancer Center
Groningen, Netherlands -
The Newcastle upon Tyne Hospitals NHS Foundation Trust | Freeman Hospital - Cancer Trials Research Centre
Newcastle upon Tyne, United Kingdom -
The Newcastle upon Tyne Hospitals NHS Foundation Trust - Freeman Hospital
Newcastle, United Kingdom -
The Newcastle upon Tyne Hospitals NHS Foundation Trust | Freeman Hospital - Cancer Trials Research Centre
Newcastle upon Tyne, Tyne and Wear, United Kingdom -
Skånes Universitetssjukhus Lund - Onkologens kliniska forskningsenhet
Lund, Sweden -
Skånes Universitetssjukhus Lund - Onkologens kliniska forskningsenhet
Lund, Skåne County, Sweden -
Skånes Universitetssjukhus - Lund - Onkologens kliniska forskningsenhet
Lund, Skåne County, Sweden -
Sahlgrenska Universitetssjukhuset - Sahlgrenska Sjukhuset - Klinisk prövningsenhet Fas I/FIH
Gothenburg, Västra Götaland County, Sweden -
Sahlgrenska Universitetssjukhuset - Klinisk prövningsenhet Fas I/FIH
Gothenburg, Västra Götaland County, Sweden -
Sahlgrenska Universitetssjukhuset - Klinisk prövningsenhet Fas I/FIH
Gothenburg, Sweden -
Sahlgrenska Universitetssjukhuset - Klinisk prövningsenhet Fas I/FIH
Göteborg, Sweden -
Karolinska Universitetssjukhuset - Fas I-enheten Solna CKC
Stockholm, Stockholm County, Sweden -
Karolinska Universitetssjukhuset - Solna - Fas I-enheten Solna CKC
Stockholm, Stockholm County, Sweden -
Karolinska Universitetssjukhuset - Fas I-enheten Solna CKC
Stockholm, Sweden -
Turku University Hospital, Turun yliopistollinen sairaala (TYKS) - Syöpäkeskus
Turku, Southwest Finland, Finland -
Turku University Hospital, Turun yliopistollinen sairaala (TYKS)
Turku, Southwest Finland, Finland -
Turku University Hospital, Turun yliopistollinen sairaala (TYKS)
Turku, Finland -
Docrates Mehiläinen Syöpäsairaala
Helsinki, Uusimaa, Finland -
Helsinki University Hospital, Comprehensive Cancer Center
Helsinki, Uusimaa, Finland -
HUS-Yhtymä, Helsingin yliopistollinen sairaala (HUS) - Syöpäkeskus
Helsinki, Uusimaa, Finland -
Kuopio University Hospital, Kuopion yliopistollinen sairaala (KYS) - Syövänhoitokeskus
Kuopio, Northern Savonia, Finland -
Kuopio University Hospital
Kuopio, Pohjois-Savo, Finland -
Kuopio University Hospital
Kuopio, Northern Savonia, Finland -
Centre hospitalier universitaire de Sherbrooke (CHUS) | Oncology
Sherbrooke, Quebec, Canada -
Centre Hospitalier Universitaire de Sherbrooke (CHUS) - Hopital Fleurimont
Sherbrooke, Quebec, Canada -
Centre Hospitalier Universitaire de Sherbrooke (CHUS) - Hopital Fleurimont
Sherbrooke, Canada -
Centre Hospitalier de l'Universite de Montreal (CHUM)
Montreal, Quebec, Canada -
Centre Hospitalier de l'Universite de Montreal (CHUM) - Hopi
Montreal, Quebec, Canada -
Centre Hospitalier de l'Universite de Montreal (CHUM) | Oncology
Montreal, Quebec, Canada -
Research Institute of the McGill University Health Centre | McConnell Centre for Innovative Medicine
Montreal, Quebec, Canada -
McGill University Health Centre (MUHC) - Research Institute (RI) - McConnell Centre for Innovative Medicine (CIM)
Montreal, Quebec, Canada -
Princess Margaret Cancer Centre - University Health Network - Department of Medical Oncology and Hematology
Toronto, Ontario, Canada -
Juravinski Cancer Centre - Clinical Trials Department
Hamilton, Ontario, Canada -
Juravinski Cancer Centre | Clinical Trials
Hamilton, Ontario, Canada -
Hamilton Health Sciences-Juravinski Cancer Centre
Hamilton, Ontario, Canada -
Hamilton Health Sciences
Hamilton, Ontario, Canada -
The University of Texas MD Anderson Cancer Center - Texas Medical Center
Houston, Texas, United States -
University of Texas MD Anderson Cancer Center - Texas Medical Center
Houston, Texas, United States -
M Health Fairview Masonic Cancer Clinic - Clinics and Surgery Center
Minneapolis, Minnesota, United States -
University of Minnesota Medical Center
Minneapolis, Minnesota, United States -
XCancer Omaha
Omaha, Nebraska, United States -
City of Hope - Duarte Cancer Center
Duarte, California, United States -
City of Hope
Duarte, California, United States -
British Columbia Cancer Agency-Vancouver Centre
Vancouver, British Columbia, Canada -
BC Cancer | Vancouver
Vancouver, British Columbia, Canada -
BC Cancer - Vancouver Site
Vancouver, British Columbia, Canada -
Yokohama City University Hospital
Yokohama, Kanagawa, Japan -
The Cancer Institute Hospital of JFCR
Koto-ku, Japan
Interested in Participating?
Check your eligibility and learn more about this study on TrialScreen.